S. 2554Patient Right to Know Drug Prices Act

2 recorded actions15 of these members are on the 2026 ballotWhat the measure does Read on Congress.gov

Sponsor: Susan M. Collins [R-ME]
Cosponsors: 25 · 14 Democrats · 10 Republicans · 1 Independent
Policy area: Health
Committee: Health, Education, Labor, and Pensions Committee
Latest action: Oct 10, 2018 · Became Public Law No: 115-263.

IntroducedMar 14, 2018
Passed the SenateSep 17, 2018
Passed the HouseSep 25, 2018
Sent to the PresidentOct 1, 2018
Became lawOct 10, 2018

What the measure doesCRS summary

Patient Right to Know Drug Prices Act

(Sec. 2) This bill amends the Public Health Service Act to prohibit a health insurance plan or pharmacy benefits manager from restricting a pharmacy from informing an enrollee of any difference between the out-of-pocket cost of a drug under the plan and the cost of the drug without health insurance coverage. (Such restrictions are commonly referred to as gag clauses.)

(Sec. 3) The bill also amends the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 to apply certain antitrust filing requirements for generic drug applicants to biosimilar biological product applicants. (Biosimilar biological products, commonly referred to as biosimilars, are biological products approved by the Food and Drug Administration based on their similarity to an already-approved biological product.) Under current law, generic drug applicants that make agreements with brand name drug companies or other generic drug applicants regarding the manufacture, marketing, or sale of their drugs must file such agreements with the Federal Trade Commission and the Department of Justice. The bill subjects biosimilar biological product applicants to the same filing requirements.

Written by the nonpartisan Congressional Research Service, describing S. 2554 as public Law on Oct 10, 2018. It is not the text of the measure; a later amendment may have changed what it does.

Roll calls on S. 25542 roll calls on this measure

Choose a roll call

Sep 17, 2018Each bar: ✓ Yea from the bottom, ✕ Nay aboveSep 17, 2018

How every member votedSenate roll call 209

Senate Sep 17, 2018 · the primary vote

On Passage of the Bill

S. 2554 As Amended

Bill Passed

98 Yea 2 Nay

Crossed both parties 2 of 100 voting members broke with their own party: 2 Republicans.

Open the official roll call

How the chamber split

One dot per member. Select a seat or a bar to filter the list.

DemocratsIndependentsRepublicansFilled: YeaRing: NayGrey: not voting or present

By party select a segment to filter

All members100 members

Democratic47 members

Independent2 members

Republican51 members

marks half of the votes cast. A party’s majority is the side most of its voting members took.

Cosponsors25 · 14 Democrats · 10 Republicans · 1 Independent

Signing on is not a vote: a member can cosponsor S. 2554 and vote against it. 4 signed when it was filed.

Who lobbied on S. 255454 organizations

Organizations that named S. 2554 in a lobbying disclosure. Only those that cited the bill by number appear, so this is a floor, not a full list.

AMERICAN COLLEGE OF RHEUMATOLOGYfiled by AMERICAN COLLEGE OF RHEUMATOLOGY, GREENBERG TRAURIG, LLPIts PAC: American College of Rheumatology

Health Issues · Medicare/Medicaid · Budget/Appropriations · Immigration8 filings · 4th Quarter (Oct 1 - Dec 31) 2018Filing

AMERICA'S HEALTH INSURANCE PLANS INC (AHIP)filed by AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)Its PAC: America's Health Insurance Plans, Inc. PAC

Health Issues · Medicare/Medicaid · Insurance · Taxation/Internal Revenue Code +1 more6 filings · 4th Quarter (Oct 1 - Dec 31) 2018Filing

PRIME THERAPEUTICSfiled by BROWN RUDNICK LLP, PRIME THERAPEUTICSIts PAC: Prime Therapeutics LLC Employee PAC

Health Issues · Medicare/Medicaid · Pharmacy · Alcohol and Drug Abuse6 filings · 3rd Quarter (July 1 - Sep 30) 2018Filing

AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATIONIts PAC: American Academy of Dermatology Association PAC

Taxation/Internal Revenue Code · Health Issues · Defense · Veterans +6 more4 filings · 3rd Quarter (July 1 - Sep 30) 2018Filing

AMERICAN PHARMACISTS ASSOCIATIONIts PAC: American Pharmacists Association PAC

Alcohol and Drug Abuse · Health Issues · Medicare/Medicaid · Consumer Issues/Safety/Products +2 more4 filings · 4th Quarter (Oct 1 - Dec 31) 2018Filing

NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALSIts PAC: National Association of Benefits & Insurance Professionals PAC

Health Issues · Taxation/Internal Revenue Code · Medicare/Medicaid · Budget/Appropriations +1 more4 filings · 4th Quarter (Oct 1 - Dec 31) 2018Filing

NATIONAL COMMUNITY PHARMACISTS ASSOCIATIONIts PAC: National Community Pharmacists Association - PAC

Medicare/Medicaid · Defense · Health Issues · Alcohol and Drug Abuse +3 more4 filings · 4th Quarter (Oct 1 - Dec 31) 2018Filing

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAIts PAC: Pharmaceutical Research & Manufacturers of America Better Government Committee

Copyright/Patent/Trademark · Budget/Appropriations · Health Issues · Medicare/Medicaid +1 more4 filings · 4th Quarter (Oct 1 - Dec 31) 2018Filing

THE CAMPAIGN FOR SUSTAINABLE RX PRICINGfiled by MEHLMAN CONSULTING, INC., ML STRATEGIES, LLC

Health Issues · Pharmacy · Medicare/Medicaid4 filings · 4th Quarter (Oct 1 - Dec 31) 2018Filing

AARP

Financial Institutions/Investments/Securities · Civil Rights/Civil Liberties · Agriculture · Transportation +13 more3 filings · 4th Quarter (Oct 1 - Dec 31) 2018Filing

133 disclosures name this measure. Retrieved from LDA.gov on 2026-10-05. Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.